# Probing the Dorsolateral Prefrontal Cortex and Central Executive Network for Improving Neuromodulation in Depression

> **NCT05224063** · NA · COMPLETED · sponsor: **Stanford University** · enrollment: 50 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DEVICE:** Individualized CEN-targeted rTMS
- **DEVICE:** Neuronavigated rTMS
- **DEVICE:** Scalp-targeted rTMS
- **DEVICE:** Sham rTMS

## Key facts

- **NCT ID:** NCT05224063
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2025-03-27
- **Final completion:** 2025-03-27
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2026-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05224063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05224063, "Probing the Dorsolateral Prefrontal Cortex and Central Executive Network for Improving Neuromodulation in Depression". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05224063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*